Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: Spain Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20061
20071
20083
20093
20103
20115
20121
20132
20145
20151
20164
20173
20183
20195
20201
20219
20224
20237
20245
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Terminated20
Recruiting9
Active, not recruiting4
Unknown status2
Enrolling by invitation2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion17
United Therapeutics8
Novartis Pharmaceuticals5
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA4
GlaxoSmithKline4
Merck Sharp & Dohme LLC4
AOP Orphan Pharmaceuticals AG3
Bayer3
Aerovate Therapeutics2
Bial - Portela C S.A.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension76
Hypertension, Pulmonary23
Hypertension4
Familial Primary Pulmonary Hypertension3
Cardiovascular Diseases2
Connective Tissue Diseases2
Eisenmenger Complex2
Lung Diseases2
Respiratory Tract Diseases2
Vascular Diseases2

Trials

Showing 76 to 76 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.